A high-ranking Senate Democrat is pushing for more answers on why doctors and patient advocates with financial ties to the pharmaceutical industry came to serve on a panel that advises the federal government on pain issues.
Sen. Ron Wyden says he is "even more concerned" about these apparent conflicts of interest after receiving a response from the National Institutes of Health, which vetted and selected the panel members.
Read Full Article »